Integra LifeSciences Holdings Corporation (FRA:IL3)

FRA:IL3 Statistics

Total Valuation

FRA:IL3 has a market cap or net worth of EUR 875.06 million. The enterprise value is 2.37 billion.

Market Cap	875.06M
Enterprise Value	2.37B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	77.89M
Shares Outstanding	n/a
Shares Change (YoY)	-0.99%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	3.47%
Owned by Institutions (%)	85.44%
Float	59.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	5.63
PS Ratio	0.62
PB Ratio	0.99
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	11.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.06, with an EV/FCF ratio of -616.45.

EV / Earnings	-5.62
EV / Sales	1.68
EV / EBITDA	8.06
EV / EBIT	17.15
EV / FCF	-616.45

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 1.94.

Current Ratio	3.14
Quick Ratio	1.46
Debt / Equity	1.94
Debt / EBITDA	5.87
Debt / FCF	-444.78
Interest Coverage	1.97

Financial Efficiency

Return on equity (ROE) is -38.71% and return on invested capital (ROIC) is 3.06%.

Return on Equity (ROE)	-38.71%
Return on Assets (ROA)	2.61%
Return on Invested Capital (ROIC)	3.06%
Return on Capital Employed (ROCE)	4.90%
Revenue Per Employee	318,540
Profits Per Employee	-96,036
Employee Count	4,396
Asset Turnover	0.43
Inventory Turnover	1.51

Taxes

Income Tax	-42.56M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.29%
50-Day Moving Average	11.49
200-Day Moving Average	13.25
Relative Strength Index (RSI)	52.22
Average Volume (20 Days)	42

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.89

Income Statement

In the last 12 months, FRA:IL3 had revenue of EUR 1.40 billion and -422.17 million in losses. Loss per share was -5.52.

Revenue	1.40B
Gross Profit	805.19M
Operating Income	136.99M
Pretax Income	-464.73M
Net Income	-422.17M
EBITDA	271.73M
EBIT	136.99M
Loss Per Share	-5.52

Balance Sheet

The company has 228.31 million in cash and 1.71 billion in debt, giving a net cash position of -1.48 billion.

Cash & Cash Equivalents	228.31M
Total Debt	1.71B
Net Cash	-1.48B
Net Cash Per Share	n/a
Equity (Book Value)	884.32M
Book Value Per Share	11.36
Working Capital	664.39M

Cash Flow

In the last 12 months, operating cash flow was 76.12 million and capital expenditures -79.96 million, giving a free cash flow of -3.85 million.

Operating Cash Flow	76.12M
Capital Expenditures	-79.96M
Free Cash Flow	-3.85M
FCF Per Share	n/a

Margins

Gross margin is 57.50%, with operating and profit margins of 9.78% and -30.15%.

Gross Margin	57.50%
Operating Margin	9.78%
Pretax Margin	-33.19%
Profit Margin	-30.15%
EBITDA Margin	19.41%
EBIT Margin	9.78%
FCF Margin	n/a

Dividends & Yields

FRA:IL3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.99%
Shareholder Yield	0.99%
Earnings Yield	-48.25%
FCF Yield	-0.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 4, 2017. It was a forward split with a ratio of 2.

Last Split Date	Jan 4, 2017
Split Type	Forward
Split Ratio	2

Scores

FRA:IL3 has an Altman Z-Score of 1.34 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.34
Piotroski F-Score	5